The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS

Scandinavian Journal of Immunology

Volumn 45, Issue 6, 1997, Pages 587-595

  Guinamard, R ^a   Fougereau, M ^a,b   Seckinger, P ^a  

^a INSERM   (France)

^b INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

AGAMMAGLOBULINEMIA; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL LINE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; X CHROMOSOME LINKAGE;

EID: 0030983422     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-447.x     Document Type: Article

References (69)

1. Conley ME. Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol 1992;10:215-38.
2. Kinnon C, Hinshelwood S, Levinsky RJ, Lovering RC. X-linked agammaglobulinemia-gene cloning and future prospects. Immunol Today 1993;14:554-8.
3. Rawlings DJ, Witte ON. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol Rev 1994;138:105-19.
4. Campana D, Farrant J, Inamdar N, Webster AD, Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol 1990;145:1675-80.
5. Milili M, Le Deist F, de Saint-Basile G, Fischer A, Fougereau M, Schiff C. Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire. J Clin Invest 1993;91:1616-29.
6. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-90.
7. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases [published erratum appears in Nature 1993;364(6435):362) [see comments]. Nature 1993;361:226-33.
8. Rawlings DJ, Saffran DC, Tsukada S et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993;261:358-61.
9. Kerner JD, Appleby MW, Mohr RN et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 1995;3:301-12.
10. Khan WN, Alt FW, Gerstein RM et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995;3:283-99.
11. Tamagnone L, Lahtinen I, Mustonen T et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994;9:3683-8.
12. Desiderio S, Siliciano JD. The Itk/Btk/Tec family of protein-tyrosine kinases. Chem Immunol 1994;59:191-210.
13. Ren R, Mayer BJ, Cicchetti P, Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993;259: 1157-61.
14. Pawson T, Gish GD. SH12 and SH3 domains: from structure to function. Cell 1992;71:359-62.
15. Jin H, Webster AD, Vihinen M et al. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA). Hum Mol Genet 1995;4:693-700.
16. Vihinen M, Cooper MD, de Saint Basile G et al. BTKbase: a database of XLA-causing mutations. International Study Group. Immunol Today 1995;16:460-5.
17. Zhu Q, Zhang M, Winkelstein J, Chen SH, Ochs HD. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families. Hum Mol Genet 1994;3: 1899-900.
18. Rigley KP, Harnett MM, Phillips RJ, Klaus GG. Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice. Eur J Immunol 1989;19:2081-6.
19. de Weers M, Brouns GS, Hinshelwood S et al. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase. which is deficient in X-linked agammaglobulinemia. J Biol Chem 1994;269:23857-60.
20. Hinshelwood S, Lovering RC, Genevier HC, Levinsky RJ, Kinnon C. The protein defective in X-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked. Eur J Immunol 1995;25:1113-16.
21. Hasbold J, Klaus GG. B cells from CBAyN mice do not proliferate following ligation of CD40. Eur J Immunol 1994;24:152-7.
22. Santos-Argumedo L, Lund FE, Heath AW et al. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int Immunol 1995;7:163-70.
23. Sato S, Katagiri T, Takaki S et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994;180:2101-11.
24. Go NF, Castle BE, Barrett R et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625-31.
25. Rawlings DJ, Scharenberg AM, Park H et al. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 1996;271:822-5.
26. Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB. Src family protein tyrosine kinases induce autoactivution of Bruton's tyrosine kinase. Mol Cell Biol 1995;15:5304-11.
27. Yang W, Malek SN, Desiderio S. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J Biol Chem 1995;270:20832-40.
28. Ferguson KM, Lemmon MA, Schlessinger J, Sigler PB. Crystal structure at 2.2 A resolution of the pleckstrin homology domain from human dynamin. Cell 1994;79:199-209.
29. Tsukada S, Simon MI, Witte ON, Katz A. Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc Natl Acad Sci USA 1994;91:11256-60.
30. Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 1994;91:9175-9.
31. Salim K, Bottomley MJ, Querfurth E et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 1997;15:6241-50.
32. Li T, Tsukada S, Satterthwaite A et al. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 1995;2:451-60.
33. Afar DEH, Park H, Howell BW, Rawlings DJ, Cooper J, Witte ON. Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol 1996;16:3465-71.
34. Cheng G, Ye ZS, Baltimore D. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc Natl Acad Sci USA 1994;91:8152-5.
35. Tarakhovsky A, Turner M, Schaal S et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995;374:467-70.
36. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995;374:470-3.
37. Fumagalli S, Totty NF, Hsuan JJ, Courtneidge SA. A target for Src in mitosis. Nature 1994;368:871-4.
38. Taylor SJ, Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 1994;368:867-71.
39. Lock P, Fumagalli S, Polakis P, McCormick F, Courtneidge SA. The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein. Cell 1996;84:23-4.
40. Meffre E, Fougereau M, Argenson J-N, Aubagnac J-M, Schiff C. Cell surface expression of surrogate light chain (ψ) in the absence of μ on human proB cell lines and normal proB cells. Eur J Immunol 1996;26:2172-80.
41. Ramos-Morales F, Druker BJ, Fischer S. Vav binds to several SH2/ SH3 containing proteins in activated lymphocytes. Oncogene 1994;9:1917-23.
42. Delattre O, Zucman J, Plougastel B et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-5.
43. Zucman J, Delattre O, Desmaze C et al. EWS and ATF-1 gene fusion induced by t(12; 22) translocation in malignant melanoma of soft parts. Nat Genet 1993;4:341-5.
44. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21; 22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994;6:146-51.
45. May WA, Gishizky ML, Lessnick SL et al. Ewing sarcoma 11; 22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLH for transformation. Proc Natl Acad Sci USA 1993;90:5752-6.
46. Zucman J, Melot T, Desmaze C et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993;12:4481-7.
47. Bailly RA, Bosselut R, Zucman J et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11; 22) translocation in Ewing sarcoma. Mol Cell Biol 1994;14:3230-41.
48. Braun BS, Frieden R, Lessnick SL, May WA, Denny CT. Identification of the target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 1995;15:4623-30.
49. Bustelo XR, Barbacid M. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 1992;256:1196-9.
50. Margolis B, Hu P, Katzav S et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs [see comments]. Nature 1992;356:71-4.
51. Alai M, Mui AL, Cutler RL, Bustelo XR, Barbacid M, Krystal G. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. J Biol Chem 1992;267:18021-5.
52. Weng WK, Jarvis L, Le Bien TW. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 1994;269:32514-21.
53. Ramos-Morales F, Romero F, Schweighoffer F et al. The proline-rich region of Vav binds to Grb2 and Grb3-3. Oncogene 1995;11:1665-9.
54. Machide M, Mano H, Todokoro K. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 1995;11:619-25.
55. Zhu Q, Zhang M, Rawlings DJ et al. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J Exp Med 1994;180:461-70.
56. Richard S, Yu D, Blumer KJ et al. Association of p62, a multi-functional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1. Mol Cell Biol 1995;15:186-97.
57. Wang LL, Richard S, Shaw AS. P62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem 1995;270: 2010-13.
58. 2+ signals. J Biol Chem 1993;268:16688-92.
59. Zucman J, Delattre O, Desmaze C et al. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11; 22) translocation breakpoints. Genes Chromosom Cancer 1992;5:271-7.
60. Clark SG, Stern MJ, Horvitz HR. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains [see comments]. Nature 1992;356:340-4.
61. Hobert O, Jallal B, Schlessinger J, Ullrich A. Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. J Biol Chem 1994; 269:20225-8.
62. Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 1995;14:257-65.
63. Matsuda T, Takahashi-Tezuka M, Fukada T et al. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 1995;85:627-33.
64. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996;5:591-604.
65. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-g2. J Exp Med 1997;184:31-40.
66. Wong G, Müller O, Clark R et al. Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. Cell 1992;69:551-8.
67. Taylor SJ, Anafi M, Pawson T, Shalloway D. Functional interaction between c-Src and its mitotic target, Sam 68. J Biol Chem 1995;270:10120-4.
68. Hamilton-Andreotti A, Bunnel SC, Feng S, Berg LJ, Schreiber SL. Regulatory intramolecular association in a tyrosine kinase of the Tec-family. Nature 1997;385:93-7.
69. Park H, Wahl MI, Afar DEH et al. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 1996;4:515-25.